{"name": "Intradigm Corporation",
 "permalink": "intradigm-corporation",
 "crunchbase_url": "http://www.crunchbase.com/company/intradigm-corporation",
 "homepage_url": "http://www.intradigm.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2000,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "therapeutics, treatment, oncology, drug",
 "alias_list": "",
 "email_address": "",
 "phone_number": "(650) 855 9696",
 "description": "Healthcare Biotechnology",
 "created_at": "Thu Jun 25 12:40:06 UTC 2009",
 "updated_at": "Thu Apr 22 11:46:28 UTC 2010",
 "overview": "\u003Cp\u003EPrivate biotechnology company that develops systematic RNA interference (RNAi) therapeutics for the treatment of serious diseases with an initial focus on oncology. The company\u00e2\u20ac\u2122s expertise in drug development and delivery serves as the foundation of Intradigm\u00e2\u20ac\u2122s RNAi platform. In particular, the company\u00e2\u20ac\u2122s proprietary RNAi Nanoplex delivery technology is unique in its ability to enable the targeted delivery of RNAi therapeutics to specific tissues through systemic administration of the drug product.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       34],
      "assets/images/resized/0005/0666/50666v1-max-150x150.png"],
     [[250,
       56],
      "assets/images/resized/0005/0666/50666v1-max-250x250.png"],
     [[316,
       72],
      "assets/images/resized/0005/0666/50666v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$37.4M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.fiercebiotech.com/press-releases/intradigm-corporation-closes-final-tranche-21-4-million-series-b-financing-philip-haw",
    "source_description": "Intradigm Corporation Closes Final Tranche of $21.4 Million Series B Financing; Philip Haworth, Ph.D. Appointed Chief Executive",
    "raised_amount": 21400000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 1,
    "funded_day": 7,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "MP Healthcare Venture Management",
         "permalink": "mp-healthcare-venture-management-inc",
         "image":
          {"available_sizes":
            [[[150,
               17],
              "assets/images/resized/0005/0688/50688v3-max-150x150.png"],
             [[250,
               29],
              "assets/images/resized/0005/0688/50688v3-max-250x250.png"],
             [[450,
               52],
              "assets/images/resized/0005/0688/50688v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Frazier Healthcare Ventures",
         "permalink": "frazier-healthcare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0003/2779/32779v1-max-150x150.png"],
             [[153,
               72],
              "assets/images/resized/0003/2779/32779v1-max-250x250.png"],
             [[153,
               72],
              "assets/images/resized/0003/2779/32779v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Astellas Venture Management",
         "permalink": "astellas-venture-management",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0004/6637/46637v3-max-150x150.png"],
             [[160,
               64],
              "assets/images/resized/0004/6637/46637v3-max-250x250.png"],
             [[160,
               64],
              "assets/images/resized/0004/6637/46637v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MediBic Alliance",
         "permalink": "medibic-alliance",
         "image":
          {"available_sizes":
            [[[132,
               32],
              "assets/images/resized/0005/0691/50691v2-max-150x150.png"],
             [[132,
               32],
              "assets/images/resized/0005/0691/50691v2-max-250x250.png"],
             [[132,
               32],
              "assets/images/resized/0005/0691/50691v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Alta Partners",
         "permalink": "alta-partners",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0003/4978/34978v1-max-150x150.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-250x250.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Lilly Ventures",
         "permalink": "lilly-ventures",
         "image":
          {"available_sizes":
            [[[150,
               71],
              "assets/images/resized/0005/5135/55135v3-max-150x150.png"],
             [[240,
               114],
              "assets/images/resized/0005/5135/55135v3-max-250x250.png"],
             [[240,
               114],
              "assets/images/resized/0005/5135/55135v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novartis Venture Fund",
         "permalink": "novartis-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0005/9083/59083v2-max-150x150.png"],
             [[250,
               117],
              "assets/images/resized/0005/9083/59083v2-max-250x250.png"],
             [[318,
               150],
              "assets/images/resized/0005/9083/59083v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Roche Venture Fund",
         "permalink": "roche-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               21],
              "assets/images/resized/0004/6088/46088v1-max-150x150.jpg"],
             [[156,
               22],
              "assets/images/resized/0004/6088/46088v1-max-250x250.jpg"],
             [[156,
               22],
              "assets/images/resized/0004/6088/46088v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://www.intradigm.com/content/newsandevents/releases/112006.htm",
    "source_description": "INTRADIGM ANNOUNCES SIGNIFICANT ENHANCEMENTS OF THE COMPANY CAPABILITIES, A NEW SERIES A FINANCING AND IMPORTANT ADDITION TO SENIOR MANAGEMENT TEAM",
    "raised_amount": 16000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 11,
    "funded_day": 21,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Alta Partners",
         "permalink": "alta-partners",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0003/4978/34978v1-max-150x150.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-250x250.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Frazier Healthcare Ventures",
         "permalink": "frazier-healthcare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0003/2779/32779v1-max-150x150.png"],
             [[153,
               72],
              "assets/images/resized/0003/2779/32779v1-max-250x250.png"],
             [[153,
               72],
              "assets/images/resized/0003/2779/32779v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Emerging Technology Partners",
         "permalink": "emerging-technology-partners",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0008/4581/84581v1-max-150x150.jpg"],
             [[250,
               33],
              "assets/images/resized/0008/4581/84581v1-max-250x250.jpg"],
             [[400,
               54],
              "assets/images/resized/0008/4581/84581v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novartis Venture Funds",
         "permalink": "novartis-ventures",
         "image":
          {"available_sizes":
            [[[150,
               14],
              "assets/images/resized/0004/4137/44137v1-max-150x150.png"],
             [[215,
               21],
              "assets/images/resized/0004/4137/44137v1-max-250x250.png"],
             [[215,
               21],
              "assets/images/resized/0004/4137/44137v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MediBic Alliance",
         "permalink": "medibic-alliance",
         "image":
          {"available_sizes":
            [[[132,
               32],
              "assets/images/resized/0005/0691/50691v2-max-150x150.png"],
             [[132,
               32],
              "assets/images/resized/0005/0691/50691v2-max-250x250.png"],
             [[132,
               32],
              "assets/images/resized/0005/0691/50691v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition":
  {"price_amount": null,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.silence-therapeutics.com/images/stories/news/2009/release_091216.pdf",
   "source_description": "Silence Therapeutics to merge with Intradigm Corp to create leading RNAi therapeutics company",
   "acquired_year": 2009,
   "acquired_month": 12,
   "acquired_day": 16,
   "acquiring_company":
    {"name": "Silence Therapeutics",
     "permalink": "silence-therapeutics",
     "image":
      {"available_sizes":
        [[[150,
           45],
          "assets/images/resized/0007/3689/73689v1-max-150x150.jpg"],
         [[232,
           71],
          "assets/images/resized/0007/3689/73689v1-max-250x250.jpg"],
         [[232,
           71],
          "assets/images/resized/0007/3689/73689v1-max-450x450.jpg"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "Headquarters",
    "address1": "3350 W Bayshore Rd, Suite 100",
    "address2": "",
    "zip_code": "94303",
    "city": "Palo Alto",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 37.435768,
    "longitude": -122.110835}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        94],
       "assets/images/resized/0005/0665/50665v1-max-150x150.png"],
      [[250,
        157],
       "assets/images/resized/0005/0665/50665v1-max-250x250.png"],
      [[450,
        283],
       "assets/images/resized/0005/0665/50665v1-max-450x450.png"]],
    "attribution": null}],
 "external_links":
  []}